Epitomee Medical Ltd (TLV:EPIT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
285.00
-2.90 (-1.01%)
Aug 24, 2026, 11:13 AM IDT

Epitomee Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.780.21-10--
Revenue Growth
265.26%-----
Gross Profit
-1.26-0.65-10--
Operating Income
-9.6-9.53-2-6.76-11.07-8.77
Net Income
-9.88-8.61-1.46-5.68-15.39-11.52
Earnings Per Share
-0.33-0.29-0.05-0.19-0.52-6.55
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8.5713.6522.0834.7946.1364.31
Total Debt
5.865.574.353.964.080.58
Net Cash (Debt)
2.718.0817.7330.8342.0563.73
Net Cash Growth
-66.43%-54.42%-42.48%-26.67%-34.03%366.78%
Net Cash Per Share
0.090.270.601.041.4336.24

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.14-7.66-8.29-7.92-9.42-5.76
Capital Expenditures
-1.55-1.83-4.62-4.07-3.7-0.4
Free Cash Flow
-9.69-9.49-12.91-12-13.12-6.16
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-162.47%--100.00%--
Operating Margin
-1233.93%-4475.12%--67.63%--
Pretax Margin
-1269.28%-4043.19%--56.82%--
Profit Margin
-1269.28%-4043.19%--56.82%--
FCF Margin
-1245.50%-4455.87%--119.96%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
37.17268.35-3.01--